RANDAL J KIRK Insider Trading Transactions
Get free email notifications about insider trading for RANDAL J KIRK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).
Latest Insider Trading Transactions of RANDAL J KIRK
Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | J | 0.00 | 24,583 | 0 | 843,044 | 818.5 K to 843 K (+3.00 %) |
Jun 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | J | 0.00 | 2,016 | 0 | 75,684 | 73.7 K to 75.7 K (+2.74 %) |
Jun 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | J | 0.00 | 20,976 | 0 | 850,355 | 829.4 K to 850.4 K (+2.53 %) |
Jun 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | J | 0.00 | 20,976 | 0 | 720,562 | 699.6 K to 720.6 K (+3.00 %) |
Jun 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | J | 0.00 | 8,977 | 0 | 114,181 | 105.2 K to 114.2 K (+8.53 %) |
Jun 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | J | 0.00 | 8,977 | 0 | 140,007 | 131 K to 140 K (+6.85 %) |
Jun 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | J | 0.00 | 8,977 | 0 | 139,052 | 130.1 K to 139.1 K (+6.90 %) |
Jun 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | J | 0.00 | 335 | 0 | 1,403 | 1.1 K to 1.4 K (+31.37 %) |
Jun 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | J | 0.00 | 73,763 | 0 | 311,287 | 237.5 K to 311.3 K (+31.05 %) |
Jun 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | J | 0.00 | 334,737 | 0 | 5,231,555 | 4.9 M to 5.2 M (+6.84 %) |
Jun 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Sell | J | 0.00 | 1,196,077 | 0 | 0 | 1.2 M to 0 (-100.00 %) |
Jun 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 30.74 | 6,506 | 199,994 | 4,896,818 | 4.9 M to 4.9 M (+0.13 %) |
Jun 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 24.35 | 32,854 | 799,995 | 182,476 | 149.6 K to 182.5 K (+21.96 %) |
May 16 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | P | 23.92 | 41,830 | 1,000,574 | 6,649,997 | 6.6 M to 6.6 M (+0.63 %) |
May 05 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Grant | A | 0.00 | 20,202 | 0 | 3,538,253 | 3.5 M to 3.5 M (+0.57 %) |
May 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 37.96 | 21,074 | 799,969 | 149,622 | 128.5 K to 149.6 K (+16.39 %) |
May 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 26.73 | 7,482 | 199,994 | 4,890,312 | 4.9 M to 4.9 M (+0.15 %) |
Apr 04 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 34.19 | 23,398 | 799,978 | 128,548 | 105.2 K to 128.5 K (+22.25 %) |
Apr 04 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 33.89 | 5,901 | 199,985 | 4,882,830 | 4.9 M to 4.9 M (+0.12 %) |
Mar 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 29.67 | 26,963 | 799,992 | 105,150 | 78.2 K to 105.2 K (+34.49 %) |
Mar 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 30.95 | 6,462 | 199,999 | 4,876,929 | 4.9 M to 4.9 M (+0.13 %) |
Feb 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 27.11 | 29,509 | 799,989 | 78,187 | 48.7 K to 78.2 K (+60.62 %) |
Feb 02 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 29.14 | 6,863 | 199,988 | 4,870,467 | 4.9 M to 4.9 M (+0.14 %) |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Option Exercise | P | 1.21 | 32,205 | 38,968 | 32,205 | |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Option Exercise | P | 0.00 | 42,941 | 0 | 42,941 | |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Option Exercise | P | 1.21 | 32,205 | 38,968 | 32,205 | |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Option Exercise | P | 0.00 | 42,941 | 0 | 42,941 | |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Option Exercise | P | 1.21 | 32,205 | 38,968 | 32,205 | |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Option Exercise | P | 0.00 | 42,941 | 0 | 42,941 | |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Option Exercise | P | 1.21 | 64,411 | 77,937 | 64,411 | |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Option Exercise | P | 0.00 | 85,882 | 0 | 85,882 | |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 577,319 | 0 | 0 | |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 288,659 | 0 | 0 | |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 517,241 | 0 | 0 | |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 1,034,482 | 0 | 0 | |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 577,319 | 0 | 0 | |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 1,034,482 | 0 | 0 | |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Buy | P | 1.00 | 317,294 | 317,294 | 894,613 | 577.3 K to 894.6 K (+54.96 %) |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Buy | C | 0.00 | 577,319 | 0 | 577,319 | 0 to 577.3 K |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Buy | P | 1.00 | 894,965 | 894,965 | 1,510,135 | 615.2 K to 1.5 M (+145.48 %) |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Buy | C | 0.00 | 461,072 | 0 | 615,170 | 154.1 K to 615.2 K (+299.21 %) |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Buy | P | 1.00 | 1,472,636 | 1,472,636 | 2,125,654 | 653 K to 2.1 M (+225.51 %) |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Buy | C | 0.00 | 344,822 | 0 | 653,018 | 308.2 K to 653 K (+111.88 %) |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Buy | P | 1.00 | 1,789,930 | 1,789,930 | 3,020,267 | 1.2 M to 3 M (+145.48 %) |
Jan 11 2016 | TBIO | TRANSGENOMIC INC | KIRK RANDAL J | 10% Owner | Buy | C | 0.00 | 922,141 | 0 | 1,230,337 | 308.2 K to 1.2 M (+299.21 %) |
Jan 05 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 30.72 | 26,041 | 799,980 | 48,678 | 22.6 K to 48.7 K (+115.04 %) |
Jan 05 2016 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 30.15 | 6,633 | 199,985 | 4,863,604 | 4.9 M to 4.9 M (+0.14 %) |
Jan 04 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Grant | A | 0.00 | 26,661 | 0 | 122,309 | 95.6 K to 122.3 K (+27.87 %) |
Dec 14 2015 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | P | 29.83 | 34,100 | 1,017,203 | 6,608,167 | 6.6 M to 6.6 M (+0.52 %) |
Dec 14 2015 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | P | 29.86 | 90,375 | 2,698,598 | 6,574,067 | 6.5 M to 6.6 M (+1.39 %) |
Dec 07 2015 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Buy | P | 30.69 | 237,525 | 7,289,642 | 6,483,692 | 6.2 M to 6.5 M (+3.80 %) |
Dec 03 2015 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 35.34 | 22,637 | 799,992 | 22,637 | 0 to 22.6 K |
Dec 03 2015 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Gift | G | 0.00 | 200 | 0 | 4,856,971 | 4.9 M to 4.9 M (0.00 %) |
Dec 03 2015 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 36.31 | 5,508 | 199,995 | 4,857,171 | 4.9 M to 4.9 M (+0.11 %) |
Dec 03 2015 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Buy | C | 1.50 | 3,381,004 | 5,071,506 | 12,219,670 | 8.8 M to 12.2 M (+38.25 %) |
Dec 03 2015 | OGEN | ORAGENICS INC | KIRK RANDAL J | 10% Owner | Buy | C | 1.50 | 3,381,004 | 5,071,506 | 12,219,670 | 8.8 M to 12.2 M (+38.25 %) |
Sep 04 2015 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Buy | P | 3.20 | 937,500 | 3,000,000 | 9,613,268 | 8.7 M to 9.6 M (+10.81 %) |
Sep 04 2015 | SYN | Synthetic Biologic ... | KIRK RANDAL J | 10% Owner | Buy | P | 3.20 | 937,500 | 3,000,000 | 9,613,268 | 8.7 M to 9.6 M (+10.81 %) |
Jul 27 2015 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Buy | P | 5.80 | 375,868 | 2,180,034 | 6,400,783 | 6 M to 6.4 M (+6.24 %) |
Jul 27 2015 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Buy | P | 5.80 | 18,003 | 104,417 | 18,003 | 0 to 18 K |
Jul 27 2015 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Buy | P | 5.80 | 582,116 | 3,376,273 | 582,116 | 0 to 582.1 K |
Jul 27 2015 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Buy | P | 5.80 | 375,868 | 2,180,034 | 6,400,783 | 6 M to 6.4 M (+6.24 %) |
Jul 27 2015 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Buy | P | 5.80 | 18,003 | 104,417 | 18,003 | 0 to 18 K |
Jul 27 2015 | FCSC | Fibrocell Science, ... | KIRK RANDAL J | 10% Owner | Buy | P | 5.80 | 582,116 | 3,376,273 | 582,116 | 0 to 582.1 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 86,556 | 0 | 86,556 | 0 to 86.6 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 173,111 | 0 | 173,111 | 0 to 173.1 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 58,746 | 0 | 58,746 | 0 to 58.7 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 176,238 | 0 | 176,238 | 0 to 176.2 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 352,477 | 0 | 352,477 | 0 to 352.5 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 111,339 | 0 | 111,339 | 0 to 111.3 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 222,680 | 0 | 222,680 | 0 to 222.7 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 395,791 | 0 | 395,791 | 0 to 395.8 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 889,513 | 0 | 889,513 | 0 to 889.5 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 1,013,146 | 0 | 2,359,608 | 1.3 M to 2.4 M (+75.25 %) |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 61,262 | 0 | 61,262 | 0 to 61.3 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 138,975 | 0 | 138,975 | 0 to 139 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 154,181 | 0 | 154,181 | 0 to 154.2 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 29,066 | 0 | 29,066 | 0 to 29.1 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 34,318 | 0 | 34,318 | 0 to 34.3 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 358,386 | 0 | 358,386 | 0 to 358.4 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 337,333 | 0 | 337,333 | 0 to 337.3 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 9,537 | 0 | 9,537 | 0 to 9.5 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 53,245 | 0 | 53,245 | 0 to 53.2 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 240 | 0 | 240 | 0 to 240 |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 40,954 | 0 | 40,954 | 0 to 41 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 23,504 | 0 | 23,504 | 0 to 23.5 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 23,349 | 0 | 23,349 | 0 to 23.3 K |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 3,479,006 | 0 | 3,479,006 | 0 to 3.5 M |
Jun 08 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Sell | J | 0.00 | 17,830,305 | 0 | 0 | 17.8 M to 0 (-100.00 %) |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 86,556 | 0 | 86,556 | 0 to 86.6 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 173,111 | 0 | 173,111 | 0 to 173.1 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 58,746 | 0 | 58,746 | 0 to 58.7 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 176,238 | 0 | 176,238 | 0 to 176.2 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 352,477 | 0 | 352,477 | 0 to 352.5 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 111,339 | 0 | 111,339 | 0 to 111.3 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 222,680 | 0 | 222,680 | 0 to 222.7 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 395,791 | 0 | 395,791 | 0 to 395.8 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 889,513 | 0 | 889,513 | 0 to 889.5 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 1,013,146 | 0 | 2,359,608 | 1.3 M to 2.4 M (+75.25 %) |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 61,262 | 0 | 61,262 | 0 to 61.3 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 138,975 | 0 | 138,975 | 0 to 139 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 154,181 | 0 | 154,181 | 0 to 154.2 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 29,066 | 0 | 29,066 | 0 to 29.1 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 34,318 | 0 | 34,318 | 0 to 34.3 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 358,386 | 0 | 358,386 | 0 to 358.4 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 337,333 | 0 | 337,333 | 0 to 337.3 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 9,537 | 0 | 9,537 | 0 to 9.5 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 53,245 | 0 | 53,245 | 0 to 53.2 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 240 | 0 | 240 | 0 to 240 |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 40,954 | 0 | 40,954 | 0 to 41 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 23,504 | 0 | 23,504 | 0 to 23.5 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 23,349 | 0 | 23,349 | 0 to 23.3 K |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Buy | J | 0.00 | 3,479,006 | 0 | 3,479,006 | 0 to 3.5 M |
Jun 08 2015 | XON | INTREXON CORP | KIRK RANDAL J | Director | Sell | J | 0.00 | 17,830,305 | 0 | 0 | 17.8 M to 0 (-100.00 %) |
May 08 2015 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Grant | A | 0.00 | 13,175 | 0 | 3,518,051 | 3.5 M to 3.5 M (+0.38 %) |
Mar 18 2015 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Option Exercise | P | 0.22 | 3,484,848 | 749,242 | 3,484,848 | |
Mar 18 2015 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Buy | P | 0.17 | 13,939,392 | 2,300,000 | 37,939,392 | 24 M to 37.9 M (+58.08 %) |
Mar 18 2015 | APHB | AmpliPhi Bioscienc ... | KIRK RANDAL J | 10% Owner | Option Exercise | P | 0.22 | 3,484,848 | 749,242 | 3,484,848 | |
Mar 18 2015 | APHB | AmpliPhi Bioscienc ... | KIRK RANDAL J | 10% Owner | Buy | P | 0.17 | 13,939,392 | 2,300,000 | 37,939,392 | 24 M to 37.9 M (+58.08 %) |
Nov 13 2003 | NOVI | CLINICAL DATA INC | KIRK RANDAL J | Director | Option Exercise | C | 0.00 | 11,289 | 0 | 0 | |
Nov 13 2003 | NOVI | CLINICAL DATA INC | KIRK RANDAL J | Director | Option Exercise | C | 0.00 | 41,682 | 0 | 0 | |
Nov 13 2003 | NOVI | CLINICAL DATA INC | KIRK RANDAL J | Director | Option Exercise | C | 0.00 | 2,388 | 0 | 0 | |
Nov 13 2003 | NOVI | CLINICAL DATA INC | KIRK RANDAL J | Director | Option Exercise | C | 0.00 | 48,085 | 0 | 0 | |
Nov 13 2003 | NOVI | CLINICAL DATA INC | KIRK RANDAL J | Director | Option Exercise | C | 0.00 | 37,716 | 0 | 0 | |
Nov 13 2003 | NOVI | CLINICAL DATA INC | KIRK RANDAL J | Director | Option Exercise | C | 0.00 | 61,505 | 0 | 0 | |
Nov 13 2003 | NOVI | CLINICAL DATA INC | KIRK RANDAL J | Director | Buy | C | 0.00 | 112,890 | 0 | 112,890 | 0 to 112.9 K |
Nov 13 2003 | NOVI | CLINICAL DATA INC | KIRK RANDAL J | Director | Buy | C | 0.00 | 416,820 | 0 | 555,162 | 138.3 K to 555.2 K (+301.30 %) |
Nov 13 2003 | NOVI | CLINICAL DATA INC | KIRK RANDAL J | Director | Buy | C | 0.00 | 23,880 | 0 | 33,091 | 9.2 K to 33.1 K (+259.26 %) |
Nov 13 2003 | NOVI | CLINICAL DATA INC | KIRK RANDAL J | Director | Buy | C | 0.00 | 480,850 | 0 | 579,883 | 99 K to 579.9 K (+485.55 %) |
Nov 13 2003 | NOVI | CLINICAL DATA INC | KIRK RANDAL J | Director | Buy | C | 0.00 | 377,160 | 0 | 433,410 | 56.3 K to 433.4 K (+670.51 %) |
Nov 13 2003 | NOVI | CLINICAL DATA INC | KIRK RANDAL J | Director | Buy | C | 0.00 | 615,050 | 0 | 1,048,191 | 433.1 K to 1 M (+142.00 %) |